InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,716.14
(
-1.00%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

barefootrunner

Send PM Follow Ignore
Followers 303
Posts 4680
Boards Moderated 0
Alias Born 11/26/2009

barefootrunner

Re: None

Wednesday, 12/07/2011 9:01:56 AM

Wednesday, December 07, 2011 9:01:56 AM

Post# of 97239
PCYC - Pharmacyclics strength an opporunity to take some profits, says RBC Capital

RBC Capital continues to view Pharmacyclics as one its favorite longs but sees some risk of a post-ASH sell-off. The firm continues to rate shares an Outperform given its proven robust efficacy of PCI-32765. :theflyonthewall

Agree 100%. Eyeing Jan 2012 puts. I think this bloated stock will experience post-ASH sell the news. Plus Rodman & Renshaw gave them a buy with PT = $20. R&R are kings of the PIPE and I wouldn't be surprised to see PCYC lay the PIPE after ASH.

Visit us at the $heff $tation

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up